Systemic inflammation-based Glasgow Prognostic Score as a prognostic indicator in chronic heart failure.

ABSTRACT:

Background

The Glasgow Prognostic Score (GPS), based on C-reactive protein and serum albumin concentrations provides useful prognostic information for patients with cancer or acute decompensated heart failure (HF). Herein, we aimed to evaluate the relationship between the GPS and long-term prognosis in patients with chronic HF.

Methods

In this large multicentre prospective observational study, part of the Chronic Heart Failure Analysis and Registry in the Tohoku District-2 (CHART-2) Study, we analysed the relationship between mortality and the GPS in 6,480 patients with chronic HF (mean age, 68 ± 13 years; 69 % male). Patients with elevated C-reactive protein levels (>1.0 mg/dL) and hypoalbuminaemia (<3.5 g/dL) received a GPS of 2; those with either received a GPS of 1, and

SUBMITTER: Namiuchi S 

PROVIDER: S-EPMC12002946 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature